tiprankstipranks
Apogee Therapeutics (APGE)
NASDAQ:APGE
US Market
APGE
Apogee Therapeutics
RESEARCH TOOLSreports

Apogee Therapeutics (APGE) Stock News & Sentiment

363 Followers
APGE: Best-in-Class Potential for Zumilokibart in Atopic Dermatitis Supports Undervalued Buy Rating
Premium
Ratings
APGE: Best-in-Class Potential for Zumilokibart in Atopic Dermatitis Supports Undervalued Buy Rating
10d ago
APGE
Apogee Therapeutics Prices Upsized Public Equity Offering
Premium
Company Announcements
Apogee Therapeutics Prices Upsized Public Equity Offering
16d ago
8K
APGE
Apogee Therapeutics: Strong Phase IIa IL‑13 Data Support Buy Rating and Long-Term Upside in Atopic Dermatitis
Premium
Ratings
Apogee Therapeutics: Strong Phase IIa IL‑13 Data Support Buy Rating and Long-Term Upside in Atopic Dermatitis
18d ago
APGE
APGE: Zumilokibart’s Best-in-Class Atopic Dermatitis Profile and Long-Acting Dosing Support Buy Rating and Re-Rating Potential
Premium
Ratings
APGE: Zumilokibart’s Best-in-Class Atopic Dermatitis Profile and Long-Acting Dosing Support Buy Rating and Re-Rating Potential
18d ago
APGE
Morning News Wrap-Up 3/23/26: Today’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up 3/23/26: Today’s Biggest Stock Market Stories!
18d ago
EA
HD
Why Did Apogee Therapeutics Stock (APGE) Soar Today?
Premium
Market News
Why Did Apogee Therapeutics Stock (APGE) Soar Today?
18d ago
APGE
Apogee Therapeutics Announces Positive Phase 2 APEX Maintenance Data
Premium
Company Announcements
Apogee Therapeutics Announces Positive Phase 2 APEX Maintenance Data
18d ago
8K
APGE
More APGE News >

APGE News on the Web

Apogee Therapeutics (APGE) Receives a Rating Update from a Top Analyst
TipRanks News
Neutral
Insider Sell: Jane Henderson Sells 2,000 Shares of Apogee Therapeutics Inc (APGE)
GuruFocus News
Neutral
Here are the 21 stocks Deutsche Bank just added to its 'fresh money' list that's beaten the S&P 500 over time
Markets Insider
Neutral
Analysts Offer Insights on Healthcare Companies: Inhibikase Therapeutics (IKT), Tvardi Therapeutics (TVRD) and Apogee Therapeutics (APGE)
TipRanks News
Bullish
Fairmount Funds Management LLC Increases Stake in Apogee Therapeutics Inc
GuruFocus News
Bullish
Apogee Therapeutics Stock Soars on Breakthrough Drug Data
TipRanks News
Bullish
Guggenheim Keeps Their Buy Rating on Apogee Therapeutics (APGE)
TipRanks News
Bullish
APGE: Best-in-Class Potential for Zumilokibart in Atopic Dermatitis Supports Undervalued Buy Rating
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
APGE
Sector Average
Media Buzz
This Week3 articles
Weekly Average16.25 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is APGE’s Media Buzz Sentiment?
3 articles about APGE were published this week. In an average week, 16.25 articles are published.
    What is APGE’s weekly average amount of articles?
    In an average week, 16.25 articles about APGE are published.
      What is APGE’s News Sentiment?
      50% of articles about APGE were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        STAAStaar Surgical
        AORTArtivion
        OWLTOwlet
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week